Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-03-12 | Adaptive Biotechnologies Corp | NEUPERT PETER M
(Director) |
M | Common Stock | A | 15000 | $0.84 - $0.84 | $12,600 |
2024-03-04 | Adaptive Biotechnologies Corp | Pellini Michael J
(Director) |
A | Common Stock | A | 31328 | $0.00 - $0.00 | $0 |
2024-03-04 | Adaptive Biotechnologies Corp | OWEN KATEY EINTERZ
(Director) |
A | Common Stock | A | 31328 | $0.00 - $0.00 | $0 |
2024-03-04 | Adaptive Biotechnologies Corp | NEUPERT PETER M
(Director) |
A | Common Stock | A | 31328 | $0.00 - $0.00 | $0 |
2024-03-04 | Adaptive Biotechnologies Corp | HERSHBERG ROBERT
(Director) |
A | Common Stock | A | 31328 | $0.00 - $0.00 | $0 |
2024-03-04 | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE ...
(Director) |
A | Common Stock | A | 31328 | $0.00 - $0.00 | $0 |
2024-03-05 | Adaptive Biotechnologies Corp | PISKEL KYLE
(Principal Accounting Officer) |
S | Common Stock | D | 7727 | $3.43 - $3.43 | $26,503 |
2024-03-04 | Adaptive Biotechnologies Corp | PISKEL KYLE
(Principal Accounting Officer) |
A | Common Stock | A | 43740 | $0.00 - $0.00 | $0 |
2024-03-05 | Adaptive Biotechnologies Corp | Taylor Stacy L
(SVP and General Counsel) |
S | Common Stock | D | 13381 | $3.43 - $3.44 | $45,961 |
2024-03-04 | Adaptive Biotechnologies Corp | Taylor Stacy L
(SVP and General Counsel) |
A | Common Stock | A | 39990 | $0.00 - $0.00 | $0 |
2024-03-05 | Adaptive Biotechnologies Corp | LO FRANCIS
(Chief People Officer) |
S | Common Stock | D | 14700 | $3.43 - $3.44 | $50,438 |
2024-03-04 | Adaptive Biotechnologies Corp | LO FRANCIS
(Chief People Officer) |
A | Common Stock | A | 99976 | $0.00 - $0.00 | $0 |
2024-03-05 | Adaptive Biotechnologies Corp | BENZENO SHARON
(Chief Commercial Ofc Imm Med) |
S | Common Stock | D | 29390 | $3.43 - $3.44 | $100,993 |
2024-03-04 | Adaptive Biotechnologies Corp | BENZENO SHARON
(Chief Commercial Ofc Imm Med) |
A | Common Stock | A | 132979 | $0.00 - $0.00 | $0 |
2024-03-05 | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE
(President) |
S | Common Stock | D | 39070 | $3.43 - $3.56 | $135,763 |
2024-03-04 | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE
(President) |
A | Common Stock | A | 175000 | $0.00 - $0.00 | $0 |
2024-03-04 | Adaptive Biotechnologies Corp | ROBINS HARLAN S
(Chief Scientific Officer) |
A | Common Stock | A | 354610 | $0.00 - $0.00 | $0 |
2024-03-05 | Adaptive Biotechnologies Corp | PETERSON TYCHO
(Chief Financial Officer) |
S | Common Stock | D | 15456 | $3.44 - $3.44 | $53,168 |
2024-03-04 | Adaptive Biotechnologies Corp | PETERSON TYCHO
(Chief Financial Officer) |
A | Common Stock | A | 147790 | $0.00 - $0.00 | $0 |
2024-03-05 | Adaptive Biotechnologies Corp | ROBINS CHAD M
(CEO and Chairman) |
S | Common Stock | D | 48673 | $3.43 - $3.44 | $167,006 |
2024-03-04 | Adaptive Biotechnologies Corp | ROBINS CHAD M
(CEO and Chairman) |
A | Common Stock | A | 354610 | $0.00 - $0.00 | $0 |
2024-03-05 | Adaptive Biotechnologies Corp | BOBULSKY SUSAN
(Chief Commercial Officer, MRD) |
S | Common Stock | D | 12991 | $3.43 - $3.44 | $44,628 |
2024-03-04 | Adaptive Biotechnologies Corp | BOBULSKY SUSAN
(Chief Commercial Officer, MRD) |
A | Common Stock | A | 132979 | $0.00 - $0.00 | $0 |
2023-12-13 | Adaptive Biotechnologies Corp | NEUPERT PETER M
(Director) |
M | Common Stock | A | 100000 | $0.84 - $0.84 | $84,000 |
2023-11-16 | Adaptive Biotechnologies Corp | PISKEL KYLE
(Principal Accounting Officer) |
S | Common Stock | D | 259 | $4.13 - $4.13 | $1,069 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |